Market Tracker

04/27 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.95
Delayed Data
As of 3:58pm ET
 -0.3992 / -4.78%
Today’s Change
5.70
Today|||52-Week Range
10.51
+29.92%
Year-to-Date
Insiders' Week: JPMorgan, Alphabet, Netflix
Apr 21 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close8.35
Today’s open8.50
Day’s range7.70 - 8.63
Volume163,681
Average volume (3 months)29,398
Market cap$111.0M
Dividend yield--
Data as of 3:58pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...-0.06-3.55%
RNNRexahn Pharmaceutica...-0.02-3.85%
GLYCGlycoMimetics Inc-0.07-1.53%
PRQRProQR Therapeutics N...+0.05+1.03%
Data as of 4:02pm ET, 04/27/2017

Financials

Last reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts